Laserfiche WebLink
MONSANTO COMPANY <br />Roundup PowerMAX0 Herbicide <br />Page: 2 / 9 <br />Version: 2.0 Effective date: 10/19/2015 <br />2.3. Appearance and odour (colour/form/odour) <br />Pale amber-Pale brown /Liquid / Odourless <br />2.4. OSHA Status <br />This product is hazardous according to the OSHA Hazard Communication Standard, 29 CFR 1910.1200. <br />Refer to section 11 for toxicological and section 12 for environmental information. <br />COMPOSITION/INFORMATION ON INGREDIENTS <br />Active ingredient <br />Potassium salt of N-(phosphonomethyl)glycine; {Potassium salt of glyphosate} <br />Com osition <br />COMPONENT CAS No. % by weight (approximate) <br />Potassium salt of glyphosate 70901-12-1 48.7 <br />Other ingredients 51.3 <br />The specific chemical identity is being withheld because it is trade secret information of Monsanto Company. <br />FIRST AID MEASURES <br />Use personal protection recommended in section 8. <br />4.1. Description of first aid measures <br />4.1.1. Eye contact: If in eyes, hold eye open and rinse slowly and gently for 15-20 minutes. Remove <br />contact lenses, if present, after first 5 minutes, then continue rinsing. Call a poison control center or <br />doctor for treatment advice. <br />4.1.2. Skin contact: Take off contaminated clothing. Rinse skin immediately with plenty of water for 15- <br />20 minutes. Call a poison control center or doctor for treatment advice. <br />4.1.3. Inhalation: If inhaled, move person to fresh air. If person is not breathing, call emergency number or <br />ambulance, then give artificial respiration, preferably mouth-to-mouth, if possible. Call a poison <br />control center or doctor for treatment advice. <br />4.1.4. Ingestion: Call poison control center or doctor immediately for treatment advice. Have person sip a <br />glass of water if able to swallow. Do not induce vomiting unless told to do so by the poison center or <br />doctor. Do not give anything by mouth to an unconscious person. <br />4.2. Most important symptoms and effects, both acute and delayed <br />4.2.1. Eye contact, short term: May cause temporary eye irritation. <br />4.2.2. Skin contact, short term: Not expected to produce significant adverse effects when recommended <br />use instructions arc followed. <br />4.2.3. Inhalation, short term: Not expected to produce significant adverse effects when recommended use <br />instructions are followed. <br />4.3. Indication of any immediate medical attention and special treatment needed <br />4.3.1. Advice to doctors: This product is not an inhibitor of cholinesterase. <br />4.3.2. Antidote: Treatment with atropine and oximes is not indicated. <br />FIRE-FIGHTING MEASURES